Talcum Powder Cancer Lawsuit

Baby Powder Lawyer News: Record Verdict Won in St. Louis

The First Ovarian Cancer Lawsuit to Allege Asbestos in Talcum Powder

Friday, May 3, 2019 - St. Louis has become the center of the action for baby powder lawyer teams, given that a majority of the successful trials have taken place in the midwest city. In July of 2018, a case brought forward by 22 victims of ovarian cancer set a new precedent for talcum powder litigation: The case's $4.7 billion represented a record verdict, and the case was the first to connect the presence of asbestos in Johnson's baby powder to ovarian cancer.

In all previous cases, the complaint alleged talc particles themselves were the cause of higher rates of ovarian cancer in women. Medical researchers have presented a theory to explain the preponderance of research linking talcum powder to ovarian cancer: When talcum powder is using for genital dusting, talc particles naturally enter the female reproductive system. Over time, the particles migrate through fallopian tubes and settle in the ovaries. Talc is not readily absorbable; talc particles have been found to remain intact in the human body for years or even decades. The presence of the talc particles results in inflammation, which makes fertile ground for cancer cells to flourish. In many cases, talc particles have been discovered in the ovaries of women suffering from ovarian cancer.

Through further research into buried Johnson & Johnson documents and internal memos, the baby powder lawyer team involved in this case and others revealed evidence showing the company's raw talc supply was contaminated with asbestos during the 1970s. This supply was used to make cosmetic products such as Johnson's Baby Powder and Shower to Shower.

While Johnson & Johnson was aware of trace quantities of asbestos in its raw talc supply, the company omitted certain test results when submitting to an FDA request. Instead of providing all known testing of its talc supply, J&J officials submitted only the tests that indicated no asbestos was present. Meanwhile, documents unearthed during discovery show the company was aware of its asbestos contamination problem and even sought expert advice. They were told talc could never be considered completely asbestos-free. Even in spite of this information, the company continued to manufacture cosmetic products containing a known carcinogen and market them for routine, everyday use for women and babies.

A jury in the City of St. Louis circuit court found in favor of the 22 plaintiffs, women and the family members of women who had suffered from ovarian cancer and had a history of using Johnson's Baby Powder or Shower to Shower in their hygiene routine over the course of decades. The jury assigned a record $4.7 billion in compensatory and punitive damages.

When Johnson & Johnson sought an appeal in December of 2018, asking that the cases be tried separately, the verdict was upheld by Judge Rex Burlison to the satisfaction of the baby powder lawyer team. Judge Burlison wrote, "substantial evidence was adduced at trial of particularly reprehensible conduct" by Johnson & Johnson, such as evidence proving company officials "knew of the presence of asbestos in products that they knowingly targeted for sale to mothers and babies, knew of the damage their products caused, and misrepresented the safety of these products for decades."

Information provided by TalcumPowderCancerLawsuit.com, a website devoted to providing news about talcum powder ovarian cancer lawsuits, as well as medical research and findings.

More Recent Talcum Powder Ovarian Cancer Lawsuit News:

View all Talcum Powder Cancer Lawsuit News

No-Cost, No-Obligation Baby Powder Lawsuit Case Review for Persons or Families of Persons Who Developed Ovarian Cancer After a History of Perineal Baby Powder Use

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The firm has represented thousands of persons in these and other products liability litigation, including DePuy hip replacement systems, which settled for $2.5 billion and Pradaxa internal bleeding, which settled for $650 million. The Onder Law Firm won over $300 million in four talcum powder ovarian cancer lawsuits in St. Louis to date and other law firms throughout the nation often seek its experience and expertise on complex litigation.

Privacy Notice: This site uses cookies for advertising, analytics and to improve our site services. By continuing to use our site, you agree to our use of cookies. For more information, see our cookie and privacy policy.